Cargando…
Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation
Stem cell transplantation is historically understood as a powerful preclinical therapeutic following stroke models. Current clinical strategies including clot busting/retrieval are limited by their time windows (tissue plasminogen activator: 3–4 h) and inevitable reperfusion injuries. However, 24+ h...
Autores principales: | Lockard, Gavin Miles, Alayli, Adam, Monsour, Molly, Gordon, Jonah, Schimmel, Samantha, Elsayed, Bassel, Borlongan, Cesar V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779061/ https://www.ncbi.nlm.nih.gov/pubmed/36555094 http://dx.doi.org/10.3390/ijms232415453 |
Ejemplares similares
-
Minor Changes for a Major Impact: A Review of Epigenetic Modifications in Cell-Based Therapies for Stroke
por: Monsour, Molly, et al.
Publicado: (2022) -
Mitochondria in Cell-Based Therapy for Stroke
por: Monsour, Molly, et al.
Publicado: (2023) -
Stem Cells: Recent Developments Redefining Epilepsy
Therapy
por: Alayli, Adam, et al.
Publicado: (2023) -
The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease
por: Gordon, Jonah, et al.
Publicado: (2022) -
Stem Cells Attenuate the Inflammation Crosstalk Between Ischemic Stroke and Multiple Sclerosis: A Review
por: Monsour, Molly, et al.
Publicado: (2023)